( the specific vector causing the disease...)45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis,Health
Navigation Links
45 People die in West Bengal due to Dengue and suspected Japanese Encephalitis
the specific vector causing the disease.”
Source : IANS,BBC Word
'"/>
Related medicine news :
1. Bad News for Short People
2. New hope on the Horizon for People Wishing to Quit Smoking
3. Prescription Drug - Helps People Stop Smoking
4. More People Seeking Treatment for Depression
5. Pain Common in People with MS
6. People with skin cancer at higher risk for other types
7. Laser Therapy Found To Help People Quit Smoking
8. Pomegranate Juice May Be The Next Best Thing For People With Heart Disease
9. New Treatment For People Allergic To Cats
10. People who fight wars may be at high risk of cardiovascular disease
11. People suffering from Alzheimer’s: can they take decisions about their treatment
Post Your Comments:
Breaking Medicine News(10 mins):Health News:When Parent Is Deployed, Kids Struggle 2Health News:When Parent Is Deployed, Kids Struggle 3Health News:Freudenberg-NOK CEO Accepts New Position 2Health News:Highmark Inc. Employees Earn $7,000 for Nonprofit Organizations 2Health News:The Country's Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 2Health News:The Country's Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 3Health News:Boies, Schiller & Flexner Commences Trial to Enforce Federal Medicaid Rights for Children 2
[0] When Parent Is Deployed, Kids Struggle[0] Freudenberg-NOK CEO Accepts New Position[0] Highmark Inc. Employees Earn $7,000 for Nonprofit Organizations[0] The Country's Largest Cooking Magazine Announces The Comfort Food Diet Cookbook[0] Boies, Schiller & Flexner Commences Trial to Enforce Federal Medicaid Rights for Children
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 2The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 3The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 4The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies 5Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 1Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 2Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 3Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 4Plastic Surgery 2009 News Briefs Research To Be Presented on Saturday October 24 58969 5Social Support 3A Impact on Health and the Bottom Line 58966 1Social Support 3A Impact on Health and the Bottom Line 58966 2Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives 58963 1Blue Cross and Blue Shield Companies Honored for Innovative Programs That Help Consumers Live Healthier Lives 58963 2
[0] Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease[0] ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program[0] The Epilepsy Research Foundation and Milken Family Foundation Announce Prestigious Translational Research Grants for Two Pioneering Epilepsy Therapies
Other Medicine Technology:Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 2Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 3Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy 4Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 2Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 3Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients 4
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |